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ABSRACT
Guillain-Barre syndrome (GBS), also known as Landry paralysis is an acute idiopathic polyneuritis, believed to be 
immunologically mediated. It usually presents as a demyelinating neuropathy with ascending weakness, however, many 
clinical variants have been well documented in the medical literature, and variants involving the cranial nerves or pure motor 
involvement with axonal injury have also been described. We report a case of a 50 year old patient who initially presented to 
the ER with hemiparesis and cranial nerve palsies simulating a cerebrovascular event. Based on neurological examination, 
CSF analysis and needle EMG finding a diagnosis of GBS was made.
Introduction:
Guillain-Barre syndrome (GBS) was first reported by Landry in 
1859 and later detailed by Guillain, Barré and Strohl, in 1916. 
The disease has become well-known internationally under the 
name of GuillainBarré Syndrome1.The disease is assumed to 
be autoimmune and operated by a preceding infection, most 
of the time respiratory or gastrointestinal infections2.Generally 
infections by microorganisms such as Campylobacter jejuni, 
CMV, Mycoplasma pneumonia, or inﬂuenza virus exist several 
weeks prior to approximately two thirds of GBS cases2. A 
small percentage of patients develop GBS after immunization 
with quadrivalent meningococcal polysaccharide conjugate 
vaccine (MCV4), following surgery or trauma, and 
bone-marrow transplantation3. It was associated with tumor 
necrosis factor alpha antagonist therapy in one report 4. In 
another report it was associated with the use of isotretinoin in 
two patients, however, a definite causal link couldn’t be 
identified5. GBS has also been linked to other autoimmune 
diseases and malignancy such as systemic lupus 
erythematosus, and Hodgkin lymphoma6.Although the classic 
description of GBS is that of a demyelinating neuropathy with 
ascending weakness, many clinical variants have been well 
documented in the medical literature, and variants involving 
the cranial nerves or pure motor involvement and axonal injury 
have also been described7. We describe a rare case of GBS 
presenting as hemiparesis.
CASE REPORT:
A 50 year old female known hypertensive for 3 years fairly 
controlled with medication, presented with h/o sudden onset, 
generalized moderate intensity headache, and 
progressiveweakness of right side of the body which was 
followed 2 days later by double vision (while looking towards 
left) and facial asymmetry. With the clinical suspicion of stroke 
her MRI brain was done at a local hospital and she was then 
referred to our hospital. On presentation to our hospital she 
had developed new onset left sided weakness 6 days later in 
addition to the persisting right sided weakness, facial 
asymmetry and diplopia. There was history of diarrhea 3 weeks 
prior to onset of weakness. She denied any history of fever, 
dysphagia, nasal regurgitation, urinary or fecal incontinence, 
backache, neck pain, photophobia, altered sensorium, 
arthralgias, oral ulcers or photosensitivity. Examination 
revealed an overweight female conscious, oriented intime, 
place and person with a respiratory rate of 20/min without use 
of accessory muscles. Her pulse was regular 70 bpm and BP 
was 130/90 mmHg. Her higher mental functions were intact. 
Motor examination revealed normal bulk withhypotonia in all 
four extremities with power of 3/5 in both upper extremities 
and 2/5 in both lower extremities (both proximally and distally). 
She had generalized areflexia with mute planter response. 
There was facial diplegia (bilateral LMN type facial palsy) and 
bilateral 6thnerve paresis (left > right), rest of the cranial 
nerves were intact and symmetric. Cerebellar examination 
wasn’t possible owing to patient’s quadriparesis and pin prick 
and proprioception was intact. Fundoscopic examination 
revealed grade 1 hypertensive changes. Chest was clear to 
auscultation.Examination of CVS and GI system was 
unremarkable. Laboratory parameters showed normal 
complete blood picture and metabolic panel. Her ESR was 18, 
ANA, RA factor and hepatitis serology werenegative. MRI brain 
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with contrast was normal. CSF showed cytoprotein 
dissociation with 5 cells, 77 mg/dl protein, and a normal 
glucose 65mg/dl(BSR134mg/dl). Nerve Conduction 
Studies/Electromyography was suggestive of a demyelinating 
polyneuropathy with secondary axonal degeneration. Left 
median, peroneal and tibial nerve showed markedly prolonged 
distal latency with decreased amplitude. Left median and 
ulnar showed mildly reduced velocity, low normal velocity was 
seen in left peroneal and normal in left tibial with mild dispersal 
of response in left tibial nerve. Left ulnar nerve showed normal 
motor and sensory response with absent response in left 
median nerve. F waves were absent in all the tested nerves. 
EMG of upper limb muscles showed reduced recruitment of 
normal duration and amplitude MUAPs while those of lower 
limbs showed reduced recruitment of mildly neuropathic 
MUAPs.  On the basis of the above clinical and lab data a 
diagnosis of GBS was made and plasmapharesis was initiated 
alongwith supportive treatment. There wasn’t much 
improvement in her power however her shortness of breath 
improved and she was discharged after 6 sessions of 
plasmapharesis and referred for rehabilitation. Unfortunately 
she was lost to follow ups.            
DISCUSSION: 
Guillain-Barré syndrome (GBS), also known as acute 
idiopathic polyneuritis, is a type of neuromuscular paralysis 
that has several variants4. In about 75% of cases it is 
preceded 1,2,7-8 weeks by an acute illness mostly respiratory 
or gastrointestinal. Camplylobacterjejuni (C. jejuni) infection is, 
overall, the most common antecedent infection and has been 
reported in up to 32% of cases. C. jejuniGBS has marked 
motor axon degeneration, an elevated anti-GM1 antibody, and 
a delayed and often incomplete recovery. There appears to be 
an over-representation on of certain strains of C. jejuni 
suggesting that the lipopolysaccharides of these organisms 
share ganglioside-like epitopes with peripheral nerves. This 
molecular mimicry appears to confuse the immune system 
resulting in a mistaken attack against neural antigens9. 
Patients usually present with complaints of finger dysesthesias 
andmuscle weakness of the lower extremities. The weakness 
may progress over hours to days to involve the arms, truncal 
muscles, cranial nerves and muscles of respiration. Variants of 
GBS may present as pure motor dysfunction (AMAN) or acute 
dysautonomia7. Half of GBS patients have some degree of 
cranial nerve dysfunction during their illness. Facial weakness 
is most common, especially if substantial limb weakness is 
present. Ophthalmoparesis is seen in 10-20% of patients with 
abducens palsy being most common which is usually bilateral. 
Acute motor axonal neuropathy (AMAN) is distinguished from 
AIDP by its involvement of exclusively motor nerves and an 
electrophysiologic pattern indicating axonal involvement. 
AMAN is seen commonly in northern China and Japan10,11, 
usually associated with a preceding Campylobacter jejuni 
infection. The clinical features and recovery are very similar to 
those of AIDP12. However, more AMAN patients require 
assisted ventilation because of impending respiratory failure.
Acute motor-sensory axonal neuropathy (AMSAN) affects both 
sensory and motor fibers and is thus a more severe form of 
AMAN 11. Clinically, it resembles AMAN variant with the 
exception that sensory symptoms are more in AMSAN. There 
is marked axonal degeneration of both motor and sensory 
nerve fibers demonstrated by severely reduced or absent 
motor and sensory responses on nerve conduction studies 
and extensive denervation on follow-up EMG studies, resulting 
in delayed and incomplete recovery. Typical presentation of 
Miller Fischer Syndrome (MFS) is that of ophthalmoplegia with 
ataxia and areflexia13. About one-quarter of patients who 
present with MFS will develop some extremity weakness, 
clearly linking this disorder to GBS. A limited form of MFS 
presents as cerebellar ataxia and hyporeflexia without 
ophthalmoplegia. Antibodies against GQ1b are present in 85 
to 90 percent of patients with MFS GBS.  Elevated antibodies 
to GQ1b suggest an immune attack against GQ1b 
gangliosides which are concentrated in the Para nodalregions 
of extraocular nerves9.  Certain features of MFS like 
ophthalmoplegia and ataxia along with encephalopathy and 
hyperreflexia characterize another variant of GBS, namely 
Bickerstaff encephalitis. It is also associated with anti-GQ1b 
antibodies and thus responds to IVIG or plasma exchange 
14,15. The pharyngeal-cervical-brachial variant of GBS is 
characterized by acute muscular weakness of the oropharynx, 
neck, and shoulder girdle with swallowing abnormality 16,17. 
It represents a localized form of axonal GBS 16,17. Facial 
weakness may be seen. Motor strength and reflexes are 
typically preserved. This form overlaps with MFS17. Some 
patients with pharyngeal-cervical-brachial weakness have 
antibodies against GQ1b, or less often GD1a. It is thought by 
some experts that MFS, Bickerstaff encephalitis, and 
pharyngeal-cervical-brachial weakness with anti-GQ1b 
antibodies constitute overlapping expressions of the 
anti-GQ1b antibody syndrome 18.Tatsumoto M et al showed 
in their study that isolated abducents nerve palsy can be 
categorized as a regional variant of Guillain-Barré syndrome or 
mild form of Fisher syndrome. They reviewed clinical profiles 
and laboratory findings for 100 cases of abducens nerve 
paresis. Tentative diagnoses made by the primary physicians 
on request of anti-ganglioside antibody testing were abducens 
nerve palsy (n=68), Fisher syndrome (n=14), acute 
ophthalmoparesis without ataxia (n=14). Serum anti-GQ1b 
antibody was positive in 2519. Yoon-Sik Jo, and  Sang-Jun 
Nav have reported an unusual case of pure motor variant of 
GBS initially presenting with hemiparesis, (a  59 year-old-male 
presenting with left sided weakness 1 day prior to admission 
who developed right sided weakness 2 days following 
admission). Electrophysiological findings were consistent with 
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pure motor GBS20. This patient presented with hemiparesis 
developing weakness of the other side few days later with NCS 
findings supporting diagnosis of GBS, similar to our patient 
however he didn’t have facial diplegia or ophthalmoparesis as 
seen in our case report moreover the neurophysiology studies 
showed pure motor GBS while it was suggestive of 
demyelinating polyneuropathy with secondary axonal 
degeneration in our patient. Guillain-Barré syndrome (GBS) is 
generally diagnosed on clinical grounds7. Electromyography 
(EMG) and nerve conduction studies (NCS) can be very helpful 
in the diagnosis as well as for prognosis. Abnormalities in NCS 
that are consistent with demyelination are sensitive and 
represent specific findings for classic GBS(AIDP wariant). 
Delayed distal latencies, slowed nerve conduction velocities, 
temporal dispersion of waveforms, conduction block, 
prolonged or absent F waves, and prolonged or absent 
H-reflexes are all findings that support demyelination. Needle 
EMG may be normal in acute nerve lesions, and it may take 
3-4 weeks for fibrillation to develop. In the acute phase, the 
only needle EMG abnormality may be abnormal motor 
recruitment, with decreased recruitment and rapid firing motor 
units in weak muscles. Unfortunately, electrodiagnostic studies 
can be completely normal inearly GBS and a normal study 
does not rule out the disease.21,22. Characteristic findings on 
CSF analysis include albuminocytologic dissociation, which is 
an elevation in CSF protein (>0.55 g/L) without an elevation in 
white blood cells. The increase in CSF protein is thought to 
reflect the widespread inflammation of the nerve roots7. Our 
patient initially presented with hemiparesis with cranial nerve 
palsies, a rare presentation of GBS her examination along with 
electrodiagnostic studies and CSF examination supported the 
diagnosis of GBS. Chauhan v et al havereported a case of GBS 
in India presenting as Bell's palsy with crossed hemiparesis 
who recovered over a month23. Kim EJ and Yuki N from 
Australia have reported reported an unusual case of GBS who 
presented with left hemiparesis at the acute phase and right 
hemifacial weakness at the recovery phase of the 
hemiparesis24. Acute hemiplegia as a clinical presentation of 
GBS could be confidently added to the category of atypical 
presentation of pediatric GBS which constitutes 11.2-24.3% 
of the whole pediatric GBS presentation reported previously.
The management of patients with Guillain-Barré syndrome 
(GBS) can be intimidating.25The unpredictable course and 
potential for rapidly producing life-threatening respiratory 
failure may prompt admission to an intensive care unit 
(ICU).Treatment of GBS though challenging, is mainly 
supportive and is centered at the anticipation and prevention 
of various complications. Immunomodulation with 
plasmapheresis and IV immunoglobulin (IVIG) helps to shorten 
the course of the disease.26-29 Patients with more severe 
disease and rapid progression of illness require extensive and 
prolonged rehabilitation and also show delayed and 
incomplete recovery.         
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